Tolvaptan

Tolvaptan is the first drug specifically for the treatment of adult polycystic kidney disease (ADPKD). It has recently been approved for use in the NHS by the National Institute of Health and Care Excellence (NICE) for some people with ADPKD

Tolvaptan is a new medication that affects how the kidneys control the concentration of urine. Taking tolvaptan will cause you to produce a larger amount of more diluted urine. Your kidney doctor can tell you more about how the medication works.